Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100055, China
NCT Number: NCT03984240
It has been shown through functional MRI (Magnetic Resonance Imaging) that patients with gliomas in eloquent areas have compensated neurological function by virtue of brain post-injury reorganization. Our previous clinical research found that mild sedation could induce and/or exacerbate neurological deficits, especially in limb motor and ataxia function, in these patients presumably by impairing functional compensation,. Nevertheless it is still very unclear how mild sedation affects sensorimotor networks in brains where reorganization may be present. Since eloquent area glioma patients are frequently subjected to sedation, anesthetics, and neurological examinations perioperatively, it is important to investigate how mild sedation interacts with motor network reorganization and functional compensation. Our research in patients with eloquent area gliomas will utilize neurological evaluations and multimodal MRI to explore the changes in brain upper limb' motor network reorganization after mild sedation by different sedatives-anesthetics. The neurological evaluations include sensorimotor function scale and testing tool. Multimodal MRI consists of 3-dimentional structure, blood oxygen-level dependent for cortical activation and diffusion tensor imaging for subcortical conduction. The data from the clinical testing and functional MRI will be processed and analyzed along with other relevant clinical information. This research will answer the question of how mild sedation affects upper limb motor function networks in brains with eloquent area gliomas. This new information will help optimize perioperative anesthetic and sedative choice for patients with eloquent area gliomas.
Looking for future studies?
Notify Me25 year–60 year
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100055, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participant will be sedated by midazolam.
Participant will be sedated by dexmedetomidine.
Time frame: 2 hours following sedation
will use fMRI and DTI
Time frame: 2 hours following sedation
will use 9-hole peg test and motor/sensory function evaluation
Time frame: 2 weeks after surgery completion
the detailed type of glioma and WHO glioma grade
Beijing Tiantan Hospital
Other
The Effects of Mild Sedation on Compensatory Upper Limb Motor Function Networks Based on Multimodal Magnetic Resonance Imaging in With Gliomas in Brain Eloquent Areas
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03042416
Basal Ganglia Diseases, Brain Diseases
Edmonton, Alberta, Canada
View Trial DetailsNCT06747728
Brain Glioma
Zhengzhou, Henan, China
View Trial DetailsNCT07580768
Dexmedetomidine, Double-J Ureteral Stent
Tanta, El-Gharbia, Egypt
View Trial DetailsNCT07564037
Adenotonsillectomy, Children
Tanta, Egypt
View Trial Details